I agree that this site is using cookies. You can find further informations here.
X
Achten, Roselie
19  results:
Search for persons X
?
1

Ocular surface disease in moderate‐to‐severe atopic dermati..:

Achten, Roselie ; Thijs, Judith ; van der Wal, Marlot...
Clinical & Experimental Allergy.  54 (2024)  4 - p. 241-252 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Switching from dupilumab to tralokinumab in atopic dermatit..:

Achten, Roselie ; Dekkers, Coco ; Bakker, Daphne...
Clinical & Experimental Allergy.  53 (2023)  5 - p. 586-589 , 2023
Link: https://doi.org/10.1111/..
 
?
3

Economic and Humanistic Burden in Paediatric Patients with ..:

Achten, Roselie ; Van der Rijst, Lisa ; Piena, Marjanne...
Acta Dermato-Venereologica.  103 (2023)  - p. adv00881 , 2023
Link: https://doi.org/10.2340/..
 
?
4

Dupilumab‐associated ocular surface disease in atopic derma..:

Achten, Roselie ; Thijs, Judith ; van der Wal, Marlot...
Allergy.  78 (2023)  8 - p. 2266-2276 , 2023
Link: https://doi.org/10.1111/..
 
?
5

High dupilumab levels in tear fluid of atopic dermatitis pa..:

Achten, Roselie ; Thijs, Judith ; van der Wal, Marlot...
Clinical and Translational Allergy.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
6

Non-Infectious Uveitis Secondary to Dupilumab Treatment in ..:

Achten, Roselie ; van Luijk, Chantal ; Thijs, Judith...
Ocular Immunology and Inflammation.  , 2023
Link: https://doi.org/10.1080/..
 
?
7

Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐s..:

Achten, Roselie ; Thijs, Judith ; van Luijk, Chantal...
Clinical & Experimental Allergy.  53 (2022)  2 - p. 239-243 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Long-term follow-up and treatment outcomes of conjunctiviti..:

Achten, Roselie ; Bakker, Daphne ; Ariens, Lieneke...
The Journal of Allergy and Clinical Immunology: In Practice.  9 (2021)  3 - p. 1389-1392.e2 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Ocular surface disease is common in moderate‐to‐severe atop..:

Achten, Roselie E. ; Bakker, Daphne S. ; van Luijk, Chantal M....
Clinical & Experimental Allergy.  52 (2022)  6 - p. 801-805 , 2022
Link: https://doi.org/10.1111/..
 
?
10

Identification of Risk Factors for Dupilumab-associated Ocu..:

Achten, Roselie E. ; Van Luijk, Chantal ; Van der Rijst, Lisa...
Acta Dermato-Venereologica.  102 (2022)  - p. adv00666 , 2022
Link: https://doi.org/10.2340/..
 
?
11

High dupilumab levels in tear fluid of atopic dermatitis pa..:

Achten, Roselie ; Thijs, Judith ; van der Wal, Marlot...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842774/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Economic and Humanistic Burden in Paediatric Patients with ..:

ACHTEN, Roselie ; VAN DER RIJST, Lisa ; PIENA, Marjanne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010183/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Association of Serum Dupilumab Levels at 16 Weeks With Trea..:

Spekhorst, Lotte S ; de Graaf, Marlies ; Loeff, Floris...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631227/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

Ocular surface disease in atopic dermatitis and the effect ..:

Achten, Roselie Edith
https://dspace.library.uu.nl/handle/1874/432946.  , 2023
Link: https://dspace.library.u..
 
?
15

Identification of Risk Factors for Dupilumab-associated Ocu..:

Achten, Roselie E ; van Luijk, Chantal M ; van der Rijst, Lisa P...
https://research.rug.nl/en/publications/c2bc0261-b372-4f40-899a-2d412db11324.  , 2022
Link: https://hdl.handle.net/1..
 
1-15